EUVIMEDOpdag EUVIMED
Open access

MicroRNA-223 limits murine hemogenic endothelial cell specification and myelopoiesis

Yinyu Wu, Umadevi Paila, Gael Genet, Karen K Hirschi

Developmental Cell · 2023

DOI: 10.1016/j.devcel.2023.05.007 ↗

At a glance

Journal article in Developmental Cell, 2023. Written by Yinyu Wu and 3 co-authors. Institution: Departments of Genetics, Yale Cardiovascular Research Center, Vascular Biology and Therapeutics Program, Yale Stem Cell Center, Yale University Schoo…. Major MEDLINE topics: Hemangioblasts, MicroRNAs. Cited 5 times so far (Crossref); 55 references. The full text is freely available in PubMed Central. Funded by: NIDDK NIH HHS, NHLBI NIH HHS, NIBIB NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Embryonic definitive hematopoiesis generates hematopoietic stem and progenitor cells (HSPCs) that are essential for the establishment and maintenance of the adult blood system. This process requires the specification of a subset of vascular endothelial cells (ECs) to become hemogenic ECs and to have subsequent endothelial-to-hematopoietic transition (EHT), and the underlying mechanisms are largely undefined. We identified microRNA (miR)-223 as a negative regulator of murine hemogenic EC specification and EHT. Loss of miR-223 leads to increased formation of hemogenic ECs and HSPCs, which is associated with increased retinoic acid signaling, which we previously showed as promoting hemogenic EC specification. Additionally, loss of miR-223 leads to the generation of myeloid-biased hemogenic ECs and HSPCs, which results in an increased proportion of myeloid cells throughout embryonic and postnatal life. Our findings identify a negative regulator of hemogenic EC specification and highlight the importance of this process for the establishment of the adult blood system.

Subjects

MeSH terms (MEDLINE)

HemangioblastsMicroRNAsMiceAnimalsMyelopoiesisHematopoietic Stem CellsHematopoiesisCell Differentiation

Author keywords

MicroRNA-223hematopoiesishematopoietic stem cellshemogenic endothelial cellsmyelopoiesisretinoic acid signaling

Substances

MicroRNAsMIRN223 microRNA, mouse

Authors and institutions

  • Departments of Genetics, Yale Cardiovascular Research Center, Vascular Biology and Therapeutics Program, Yale Stem Cell Center, Yale University School of Medicine, New Haven, CT 06510, USA; Department of Cell Biology, C…
  • Department of Cell Biology, Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908, USA.

Funding

  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • NIBIB NIH HHS
  • American Heart Association
  • University of Virginia
  • Yale University
  • National Institutes of Health

Cite

APA

Wu, Y., Paila, U., Genet, G., & Hirschi, K. K. (2023). MicroRNA-223 limits murine hemogenic endothelial cell specification and myelopoiesis. Developmental Cell. https://doi.org/10.1016/j.devcel.2023.05.007

Vancouver

Wu Y, Paila U, Genet G, Hirschi KK. MicroRNA-223 limits murine hemogenic endothelial cell specification and myelopoiesis. Developmental Cell. 2023. doi:10.1016/j.devcel.2023.05.007

BibTeX
@article{Wu2023,
  author = {Wu, Yinyu and Paila, Umadevi and Genet, Gael and Hirschi, Karen K},
  title = {MicroRNA-223 limits murine hemogenic endothelial cell specification and myelopoiesis},
  journal = {Developmental Cell},
  year = {2023},
  doi = {10.1016/j.devcel.2023.05.007}
}
Start for free →